Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Argus Health
Covington
Moodys
Cerilliant
Express Scripts
Cantor Fitzgerald
Queensland Health
Dow

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,439,241

« Back to Dashboard

Which drugs does patent 7,439,241 protect, and when does it expire?

Patent 7,439,241 protects MIRVASO and is included in one NDA.

This patent has sixty-four patent family members in twenty-four countries.
Summary for Patent: 7,439,241
Title:Compounds, formulations, and methods for treating or preventing rosacea
Abstract: In methods, compounds, and topical formulations for treatment of rosacea incorporating compounds represented by the formulas below: ##STR00001## wherein each of R.sub.1, R.sub.2, and R.sub.3 is independently hydrogen, hologen, alkyl, or alkoxy; each of R.sub.4 and R.sub.5 is independently hydrogen, alkyl, or alkoxy; and each of R.sub.6 and R.sub.7 is independently hydrogen, nitro, alkyl, or alkoxy; wherein each of A.sub.1, A.sub.3, and A.sub.4 is independently hydrogen or alkyl; and A.sub.2 is independently hydrogen or hydroxy; and wherein each of B.sub.1, B.sub.2, and B.sub.3 is independently hydrogen, hydroxy, or alkoxy; and each of B.sub.4 and B.sub.5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat rosacea and its symptoms.
Inventor(s): DeJovin; Jack A. (New Brunswick, NJ), DeJovin; Isabelle Jean (New Brunswick, NJ)
Assignee: Galderma Laboratories, Inc. (Fort Worth, TX)
Application Number:10/853,585
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 7,439,241

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs Lp MIRVASO brimonidine tartrate GEL;TOPICAL 204708-001 Aug 23, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,439,241

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,861,632 Methods and compositions for safe and effective treatment of erythema ➤ Subscribe
8,993,571 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders ➤ Subscribe
7,838,563 Compounds, formulations, and methods for ameliorating telangiectasias ➤ Subscribe
8,557,817 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders ➤ Subscribe
8,513,247 Methods and compositions for safe and effective treatment of erythema ➤ Subscribe
8,859,551 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders ➤ Subscribe
8,513,249 Methods and compositions for safe and effective treatment of erythema ➤ Subscribe
8,231,885 Compounds, formulations, and methods for ameliorating telangiectasis ➤ Subscribe
8,410,102 Methods and compositions for treating or preventing erythema ➤ Subscribe
8,426,410 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,439,241

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary E033143 ➤ Subscribe
Israel 172612 ➤ Subscribe
Japan 2008500356 ➤ Subscribe
Australia 2005247467 ➤ Subscribe
Australia 2011231543 ➤ Subscribe
Brazil PI0511519 ➤ Subscribe
Spain 2547336 ➤ Subscribe
Canada 2530938 ➤ Subscribe
Hong Kong 1164126 ➤ Subscribe
Canada 2567401 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Queensland Health
Daiichi Sankyo
Moodys
Medtronic
AstraZeneca
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot